Renske J E van den Bijgaart

3PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 25, 2026
In Vivo Analysis of Neuroblastoma Targeting Potential of aGD2-SIRPα Fusion Antibodies for Local CD47 Blockade.

Fabian Schuurmans, Matthia G M Boros, Renske J E van den Bijgaart

|Oct 13, 2025
IL2/IL15 Signaling Induces NK Cell Production of FLT3LG, Augmenting Anti-PD-1 Immunotherapy.

Shayan C Avanessian, Renske J E van den Bijgaart, Nayvin W Chew

|Oct 07, 2025
Development of aGD2-SIRPα Fusion Antibodies Targeting Neuroblastoma and the Innate Immune Checkpoint Receptor CD47.

Fabian Schuurmans, Anja Wittner, Renske J E van den Bijgaart

Pageof 1